Characteristic | Total, n = 496 (%) | Negatives, n = 365 (%) | OROV, n = 131 (%) | Co-infections | ||||
---|---|---|---|---|---|---|---|---|
OROV, n = 82 (%) | OROV/DENV, n = 36 (%) | OROV/ZIKV, n = 9 (%) | OROV/CHIKV, n = 1 (%) | Others**, n = 3 (%) | ||||
Age (years) | ||||||||
< 5 | 39 (7.9) | 31 (8.5) | 8 (6.1) | 6 (7.3) | 2 (5.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
5–11 | 68 (13.7) | 42 (11.5) | 26 (19.8)* | 20 (24.4)* | 6 (16.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
12–17 | 56 (11.3) | 43 (11.8) | 13 (9.9) | 9 (11.0) | 1 (2.8) | 3 (33.3) | 0 (0.0) | 0 (0.0) |
18–39 | 146 (29.4) | 113 (31.0) | 33 (25.2) | 18 (22.0) | 9 (25.0) | 3 (33.3) | 1 (100.0) | 2 (66.7) |
40–59 | 109 (22.0) | 87 (23.8) | 22 (16.8) | 14 (17.1) | 5 (13.9) | 2 (22.2) | 0 (0.0) | 1 (33.3) |
≥ 60 | 78 (15.7) | 49 (13.4) | 29 (22.1)* | 15 (18.3) | 13 (36.1)* | 1 (11.1) | 0 (0.0) | 0 (0.0) |
χ2-test, p value | 0.823 | 0.017 | 0.029 | 0.006 | ND | ND | ND | |
F-test, p-value | 0.025 | 0.004 | 0.001 | |||||
Gender | ||||||||
Male | 226 (45.6) | 154 (42.2) | 72 (55.0) | 43 (52.4) | 24 (66.7) | 4 (44.4) | 0 (0.0) | 1 (33.3) |
Female | 270 (54.4) | 211 (57.8) | 59 (45.0) | 39 (47.6) | 12 (33.3) | 5 (55.6) | 1 (100.0) | 2 (66.7) |
F-test, p-value | 0.006 | < 0.001 | 0.138 | 0.640 | 0.009 | ND | ND | ND |